AI assistant
NEOGENOMICS INC — Director's Dealing 2021
Jul 8, 2021
32227_dirs_2021-07-07_1b0dcff6-e0bf-4bbf-8163-8db5f3bbbff6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2021-07-05
Reporting Person: Wallar Gina M (President, Pharma Services)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4117 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $9.22 | 2023-04-19 | Common Stock (6667.0) | Direct | |
| Stock Option (Right to Buy) | $13.87 | 2023-12-12 | Common Stock (8334.0) | Direct | |
| Stock Option (Right to Buy) | $20.83 | 2026-05-01 | Common Stock (7153.0) | Direct | |
| Stock Option (Right to Buy) | $27.34 | 2027-05-01 | Common Stock (7879.0) | Direct | |
| Stock Option (Right to Buy) | $48.99 | 2028-05-01 | Common Stock (8595.0) | Direct |
Footnotes
F1: On April 19, 2018, Ms. Wallar was granted 20,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.
F2: On December 12, 2018, Ms. Wallar was granted 25,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F3: On May 1, 2019, Ms. Wallar was granted 9,537 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F4: On May 1, 2020, Ms. Wallar was granted 7,879 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F5: On May 1, 2021, Ms. Wallar was granted 8,595 stock options. The options vest ratably over the first four anniversary dates of the grant date.